CAF4 Antibody

What is Carbonic Anhydrase 4 (CA4) and what biological functions does it perform?

Carbonic Anhydrase 4 (CA4) is a membrane-associated enzyme that catalyzes the reversible hydration of carbon dioxide into bicarbonate and protons, playing a critical role in maintaining intracellular and extracellular pH homeostasis . It may stimulate the sodium/bicarbonate transporter activity of SLC4A4, which also contributes to pH regulation . CA4 is particularly essential for acid overload removal from the retina and retina epithelium, and for acid release in the choriocapillaris in the choroid . Unlike some other carbonic anhydrase isoforms, CA4 is glycosylphosphatidylinositol (GPI)-anchored to the cell membrane, with its catalytic domain facing the extracellular environment.

Researchers should consider the following validation approach:

• Cross-reactivity assessment: The Human Carbonic Anhydrase IV/CA4 Antibody (MAB2186) shows approximately 10% cross-reactivity with recombinant human CA1, CA2, and recombinant mouse CA4, but does not cross-react with human CA3, 8, 9, 10, 12, 13, or 14 .

• Control experiments:

  • Positive controls: tissues/cells known to express CA4

  • Negative controls: tissues/cells lacking CA4 expression

  • Peptide competition assays using the immunogen

  • Knockout/knockdown validation when available

• Multiple detection methods: Confirm results using orthogonal techniques (e.g., mRNA expression, enzyme activity assays).

How does epitope distance from the cell membrane affect CA4 antibody efficiency?

The distance of an antibody epitope from the cell membrane significantly influences effector mechanisms engaged during antibody-target interactions:

• Complement Dependent Cytotoxicity (CDC): Studies demonstrate that CDC is more effective when antibodies target epitopes proximal to the cell membrane . When epitopes are positioned farther from the membrane, CDC activity diminishes substantially, with up to 50% reduction in lysis at saturating antibody concentrations .

• Antibody Dependent Cellular Cytotoxicity (ADCC): Similar to CDC, ADCC efficacy is greater when antibodies target membrane-proximal epitopes .

• Antibody Dependent Cellular Phagocytosis (ADCP): Conversely, ADCP is more efficient when antibodies bind to epitopes positioned farther from the cell membrane .

For CA4, which is GPI-anchored to the membrane, these considerations are relevant when selecting antibodies for therapeutic applications or functional studies that might engage immune effector mechanisms.

Immunohistochemistry/Immunofluorescence:

• Fixation method optimization: Different fixatives (PFA vs. methanol) may affect GPI-anchor integrity and epitope accessibility.

• Antigen retrieval: Test multiple methods (heat-induced vs. enzymatic) to determine optimal epitope exposure.

• Blocking conditions: Thoroughly block to prevent non-specific binding, especially in tissues with high endogenous biotin or peroxidase activity.

• Antibody concentration: Perform titration experiments to determine optimal antibody concentration that maximizes specific signal while minimizing background.

• Detection system selection: Choose appropriate secondary antibodies or detection systems compatible with experimental design and tissue type.

ADCP Assay Protocol Based on Literature:

Based on methodologies described in the literature , the following protocol can be adapted for CA4 antibody studies:

• Label target cells with 5μM CFSE for 10 minutes at room temperature

• Wash cells in complete media

• Opsonize labeled targets with appropriate CA4 antibody concentrations

• Co-culture at 5:1 Target:Effector ratio with bone marrow-derived macrophages in 96-well plates for 1 hour at 37°C

• Label macrophages with appropriate markers (e.g., anti-F4/80-APC) for 15 minutes at room temperature

• Wash twice with PBS

• Keep plates on ice, scrape wells to collect macrophages

• Assess phagocytosis by flow cytometry by determining the percentage of F4/80+CFSE+ cells

What are the key considerations when investigating CA4 in specialized tissues like the retina?

Given CA4's essential role in acid overload removal from the retina and retina epithelium , researchers should consider:

• Tissue preservation: Optimize fixation protocols that preserve retinal architecture while maintaining epitope accessibility.

• Background reduction: Implement strategies to minimize autofluorescence, which is pronounced in retinal tissues.

• Co-localization studies: Combine CA4 antibodies with markers for specific retinal cell types (photoreceptors, bipolar cells, etc.) to determine precise localization.

• Functional assays: Correlate CA4 expression with pH measurements in retinal tissues using ratiometric pH indicators.

• Disease models: Examine CA4 expression changes in retinal degeneration or diabetic retinopathy models where pH dysregulation may contribute to pathology.

How can researchers address cross-reactivity issues with CA4 antibodies?

What experimental approaches can optimize the detection of CA4-protein interactions?

• Co-immunoprecipitation: Use CA4 antibodies to pull down protein complexes, then probe for potential interaction partners like SLC4A4 .

• Proximity Ligation Assay (PLA): Detect CA4 interactions with other proteins in situ with high specificity using pairs of antibodies against CA4 and potential binding partners.

• FRET/BRET analysis: For studying dynamic interactions in living cells, using fluorescent or bioluminescent fusion proteins.

• Cross-linking studies: Employ membrane-impermeable cross-linkers to stabilize interactions before immunoprecipitation with CA4 antibodies.

• Surface Plasmon Resonance: For in vitro quantification of binding kinetics between purified CA4 and potential interaction partners.

How are CA4 antibodies being utilized in disease-related research?

While the search results don't explicitly discuss disease applications, CA4's crucial role in pH regulation suggests several potential research areas:

• Retinal pathologies: Given CA4's role in acid removal from the retina , antibodies can help investigate its involvement in conditions like diabetic retinopathy or macular degeneration.

• Renal disorders: CA4's involvement in pH regulation suggests potential applications in studying renal tubular acidosis and other kidney conditions.

• Cancer research: Tumor microenvironment acidification is a hallmark of cancer progression; CA4 expression analysis using antibodies may reveal its contribution to this phenomenon.

• Therapeutic targeting: Understanding the impact of epitope location on effector functions could inform the development of therapeutic antibodies against CA4 in relevant diseases.

What considerations should guide the development of next-generation CA4 antibodies?

• Epitope selection: Based on findings regarding epitope distance from the membrane , researchers should select epitopes that favor particular effector functions (CDC, ADCC, or ADCP) depending on the intended application.

• Isoform specificity: Engineer antibodies with enhanced specificity to distinguish CA4 from other carbonic anhydrase isoforms, especially CA1 and CA2 .

• Recombinant formats: Consider developing single-chain variable fragments (scFvs) or nanobodies for applications requiring better tissue penetration or reduced immunogenicity.

• Conjugated antibodies: Develop fluorophore-conjugated or enzyme-conjugated CA4 antibodies to enhance detection sensitivity and enable multiplexed approaches.

• Humanized variants: For potential therapeutic applications, develop humanized versions to minimize immunogenicity while maintaining binding specificity.